Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Vienna Prograf and Endothelial Progenitor Cell Study

This study has been completed.
Information provided by (Responsible Party):
Gere Sunder-Plassmann, Medical University of Vienna Identifier:
First received: September 10, 2005
Last updated: February 4, 2014
Last verified: February 2014